Any feedback?
Please rate this page
(all_enzymes.php)
(0/150)

BRENDA support

1.5.1.34: 6,7-dihydropteridine reductase

This is an abbreviated version!
For detailed information about 6,7-dihydropteridine reductase, go to the full flat file.

Word Map on EC 1.5.1.34

Reaction

a 5,6,7,8-tetrahydropteridine
+
NAD(P)+
=
a 6,7-dihydropteridine
+
NAD(P)H
+
H+

Synonyms

7,8-dihydrobiopterin reductase, BmDhpr, DHPR, dicDHPR, dihydropteridine reductase, dihydropteridine reductase (NADH), DQPR gene product, EC 1.6.99.10, EC 1.6.99.7, EcDHPR, More, NADH-dihydropteridine reductase, NADPH-dihydropteridine reductase, NADPH-specific dihydropteridine reductase, NfsB, NprA nitroreductase, PTR2, QDPR, quinoid dihydropteridine reductase, reductase, dihydropteridine (reduced nicotinamide adenine dinucleotide)

ECTree

     1 Oxidoreductases
         1.5 Acting on the CH-NH group of donors
             1.5.1 With NAD+ or NADP+ as acceptor
                1.5.1.34 6,7-dihydropteridine reductase

Inhibitors

Inhibitors on EC 1.5.1.34 - 6,7-dihydropteridine reductase

Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
(R)-2,10,11-trihydroxy-N-n-propylaporphine
(R)-2,10,11-trihydroxyaporphine
(R)-2,11-dihydroxy-10-methoxy-aporphine
(R)-apocodeine
(R)-apomorphine
(R)-N-chloroethylnorapomorphine
(R)-N-hydroxyethylnorapomorphine
(R)-N-n-propylaporphine
(R)-N-n-propylnorapomorphine
(R)-norapomorphine
(S)-2,10,11-trihydroxyaporphine
(S)-bulbocapnine
(S)-N-n-propylnorapomorphine
1-methyl-4-(3',4'-dihydroxyphenyl)-1,2,3,6-tetrahydropyridine
1-methyl-4-(3'-methoxy-4'-hydroxyphenyl)-1,2,3,6-tetrahydropyridine
1-methyl-4-(4'-chlorophenyl)-1,2,3,6-tetrahydropyridine
1-methyl-4-(4'-hydroxyphenyl)-1,2,3,6-tetrahydropyridine
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
2,4-diamino-7,8-dihydropteroylglutamic acid
-
-
2,4-Diaminopteridine
-
-
2,4-diaminopteroic acid
-
-
2,4-diaminopteroylglutamic acid
-
-
2,6-dichlorophenolindophenol
3',4'-deoxynorlaudanosolinecarboxylic acid
-
noncompetitive vs. quinoid 2-amino-6,7-dimethyl-4-hydroxydihydropteridine and NADH
3(4-hydroxyphenyl)pyruvate
3-iodotyrosine
-
weak inhibition
3-O-methyldopamine
-
0.06 mM, 50% inhibition
3-O-Methylepinephrine
-
0.18 mM, 50% inhibition
3-phenylpyruvic acid
4-(3',4'-dihydroxyphenyl)-1,2,3,6-tetrahydropyridine
4-(3'-methoxy-4'-hydroxyphenyl)-1,2,3,6-tetrahydropyridine
4-(4'-chlorophenyl)-1,2,3,6-tetrahydropyridine
4-(4'-hydroxyphenyl)-1,2,3,6-tetrahydropyridine
4-hydroxyphenyllactate
4-O-Methyldopamine
-
0.069 mM, 50% inhibition
4-phenyl-1,2,3,6-tetrahydropyridine
4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol
5,5'-dithiobis(2-nitrobenzoate)
5-Hydroxydopamine
-
0.042 mM, 50% inhibition
6-Hydroxydopamine
-
0.029 mM, 50% inhibition
Adrenochrome
-
-
alpha-Methyltyrosine
-
1.1 mM, 50% inhibition
aminochrome
-
oxidation product of adrenaline, competitive vs. NADH
aminopterin
catecholamine
-
-
CdCl2
-
0.1 mM, complete inactivation
cis-Diaminodichloroplatinum
-
-
CoCl2
-
0.01 mM, 30% inhibition
dopachrome
-
0.6 mM, 50% inhibition
dopamine
epinephrine
-
0.13 mM, 50% inhibition
H2O2
regulatory function in vivo, above 0.03 mM, oxidation of Met146 and Met151 leads to inactivation of the enzyme due to disruption of the NADH-binding site
HgCl2
higenamine
-
noncompetitive vs. quinoid 2-amino-6,7-dimethyl-4-hydroxydihydropteridine and NADH
higenamine-1-carboxylic acid
-
noncompetitive vs. quinoid 2-amino-6,7-dimethyl-4-hydroxydihydropteridine
iodoacetamide
-
-
K2PtCl4
-
0.208 mM, half-life of inactivation: 3.1 min, NADH and 2 mM dithiothreitol completely protect
L-beta-3,4-dihydroxyphenylalanine
L-thyroxine
-
mixed-type inhibition
L-tyrosine
m-tyramine
methopterin
methotrexate
MgCl2
-
0.1 mM, complete inactivation
MnCl2
-
0.1 mM, complete inactivation
N-bromosuccinimide
-
-
N-ethylmaleimide
N-Methyldopamine
-
0.027 mM, 50% inhibition
NAD+
-
competitive vs. NADH
NADP+
-
competitive vs. NADPH
noradrenaline
-
-
norepinephrine
-
0.2 mM, 50% inhibition
o-hydroxyphenylacetic acid
octopamine
-
0.19 mM, 50% inhibition
p-chloromercuribenzoate
phenylacetic acid
phenylalanine
-
-
Phenyllactate
-
-
phenylpyruvate
quinonoid 2,4-diamino-7,8-dihydropteroylglutamic acid
-
-
quinonoid 6,6,8-trimethyl-7,8-dihydro(6H)pterin
-
0.2 mM, 50% inhibition
quiononoid 2,4-diamino-7,8-dihydropteroylglutamic acid
-
-
salsolinol
-
noncompetitive vs. quinoid 2-amino-6,7-dimethyl-4-hydroxydihydropteridine
serotonin
-
-
tetrahydrobiopterin
-
above 0.05 mM, substrate inhibition
trans-Diaminodichloroplatinum
-
-
trans-Pt(NH3)Cl2
-
1 mM, 96% inactivation after 2 h
tryptophan
-
-
tyramine
[4-hydroxyphenyl]acetic acid
-
-
additional information
-